Free tool
Stocks far below their 52-week high
We cover 8 companies trading at least 50% below their own 52-week high. The median market value in the group is $4.23B. Across the group, the median move over the past trading day is −1.06%. Price change over the past year runs from −62.0% to −23.6% across the middle 80 percent of the group, with a median of −49.0%.
Other lists in this group
Table
8 of 4,095 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| PODD | Insulet Corporation | $9.94B | Mid cap | −57.12% |
| HIMS | Hims & Hers Health, Inc. | $6.96B | Mid cap | −32.22% |
| COH.AX | Cochlear Limited | $6.39B | Mid cap | −53.79% |
| DOCS | Doximity, Inc. | $4.41B | Mid cap | −63.61% |
| 4506.T | Sumitomo Pharma Co., Ltd. | $4.05B | Mid cap | −3.59% |
| RGC | Regencell Bioscience Holdings Limited | $2.72B | Mid cap | −61.38% |
| EBO.AX | EBOS Group Limited | $2.60B | Mid cap | −37.83% |
| ADMA | ADMA Biologics, Inc. | $2.16B | Mid cap | −44.17% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.